The free fatty acid receptor 1 (FFA1/GPR40) is highly expressed in pancreatic β-cells and activated by medium and long-chain fatty acids.1 There is evidence of a link between FFA1/GPR40 and the ability of fatty acids to amplify glucose-stimulated insulin secretion, making this signaling pathway a potential target for regulating diabetes, obesity, and other metabolic disorders.2,3 CAY10587 is a selective FFA1/GPR40 agonist (EC50 = 32 nM) that does not exhibit activity on the related FFA receptors FFA2/GPR43 or FFA3/GPR41.4 At 100 nM, CAY10587 increases glucose-stimulated insulin secretion in the rat insulin-secreting cell line INS-1E.4
1
Briscoe, C.P., Tadayyon, M., Andrews, J.L., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem278(13)11303-11311(2003).
2
Itoh, Y., Kawamata, Y., Harada, M., et al. Free fatty acids regulate insulin secretion from pancreatic b cells through GPR40. Nature422173-176(2003).
3
Steneberg, P., Rubins, N., Bartoov-Shifman, R., et al. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab1245-258(2005).
4
Christiansen, E., Urban, C., Merten, N., et al. Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA1/GPR40), a potential target for the treatment of type II diabetes. J Med Chem517061-7064(2008).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
CC1=C(C#CC2=CC=C(CCC(O)=O)C=C2)C=CC=C1
Background Reading
Briscoe, C.P., Tadayyon, M., Andrews, J.L., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem278(13)11303-11311(2003).
Itoh, Y., Kawamata, Y., Harada, M., et al. Free fatty acids regulate insulin secretion from pancreatic b cells through GPR40. Nature422173-176(2003).
Steneberg, P., Rubins, N., Bartoov-Shifman, R., et al. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab1245-258(2005).
Christiansen, E., Urban, C., Merten, N., et al. Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA1/GPR40), a potential target for the treatment of type II diabetes. J Med Chem517061-7064(2008).